GT Molecular

4 articles about GT Molecular

• GT Molecular Releases Respiratory Panels and Poliovirus Typing Assays for Leading PCR Platforms

  12/20/2022

  GT Molecular, a company providing ultrasensitive PCR assays and national testing services for wastewater-based epidemiology, cancer, and pathogens, is releasing a series of high-performance Respiratory Panels and Polio Typing Assays for several major PCR platforms.

• GT Molecular Announces Highly Sensitive Digital PCR and Real Time qPCR Kits for hMPXV (Human Monkeypox)

  7/28/2022

  GT Molecular, a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels has implemented a highly sensitive, wastewater-based test for hMPXV.

• GT Molecular Ships its Patent-Pending Multiplexed RT-qPCR Test for the Omicron and Delta Coronavirus Variants

  1/27/2022

  GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529.

• GT Molecular Announces a Highly Sensitive Wastewater Testing Service for the Omicron Coronavirus Variant

  12/8/2021

  GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529.